Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial.
Journal: PloS one
Published: November 16, 2021
Corrigendum to "Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy" [Neuromuscular Disorders, Vol. 30 (6) 2020, 492-502].
Journal: Neuromuscular disorders : NMD
Published: January 16, 2021
Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: January 27, 2020
Showing 1-3 of 3
Last Updated: 09/26/2026